跳转至内容
Merck
  • Formulation and bioequivalence of two Valsartan/Amlodipine immediate release tablets after a single oral administration.

Formulation and bioequivalence of two Valsartan/Amlodipine immediate release tablets after a single oral administration.

Pakistan journal of pharmaceutical sciences (2014-07-13)
Abdel Naser Zaid, Salam Natur, Aiman Qaddomi, Murad Abualhasan, Rowa Al-Ramahi, Naser Shraim, Saed Khammash, Nidal Jaradat
摘要

The aim of this study was to formulate a film-coated Valsartan/Amlodipine (VS/AM) immediate release tablets and to evaluate their in vivo release profile. VS/AM core tablets were manufactured using dry granulation method. Opadry aqueous coating dispersion was used as film coating material. Dissolution of the film coated tablets was tested in 900 ml of 0.5% SLS media, bioequivalence of tablets was tested by comparisons against the reference brand product. The ICH guidelines were used to evaluate the stability of the obtained tablets. The coated tablets were subjected to gastric pH, and drug release was analyzed using HPLC system to evaluate the efficiency of the film coat. The coated tablets had no defects. VS/AM release met the FDA guidelines for bioequivalence studies. Statistical comparison of the main pharmacokinetic parameters showed no significant difference between test and reference. These findings suggest that aqueous film coating with Opadry system is an easy and economical approach for preparing stable film coated VS/AM tablets without compromising their in vivo drugs release.

材料
货号
品牌
产品描述

Sigma-Aldrich
苯磺酸氨氯地平, ≥98% (HPLC)
USP
苯磺酸氨氯地平(钙拮抗药), United States Pharmacopeia (USP) Reference Standard
Supelco
苯磺酸氨氯地平, Pharmaceutical Secondary Standard; Certified Reference Material
苯磺酸氨氯地平, European Pharmacopoeia (EP) Reference Standard
氨氯地平, European Pharmacopoeia (EP) Reference Standard